Understanding Down Syndrome
What You Need to Know About Diagnosis, Testing, and Life with Trisomy 21
What Is Down Syndrome?
Down syndrome is one of the most common chromosomal conditions in the world, affecting approximately 1 in every 700 babies born in the United States. It occurs when a person is born with an extra copy of chromosome 21 — a condition known as Trisomy 21. Chromosomes are thread-like structures inside our cells that carry genetic information. Typically, humans have 46 chromosomes arranged in 23 pairs. In people with Down syndrome, there are 47 chromosomes, and this additional genetic material changes how the brain and body develop.
Named after British physician John Langdon Down, who first described the condition in 1866, Down syndrome is not a disease — it is a genetic condition that exists on a spectrum. No two individuals with Down syndrome are exactly alike. While the condition does increase the likelihood of certain health challenges, many people with Down syndrome lead rich, fulfilling lives, participate actively in their communities, and reach significant personal milestones.
What Are the Different Types of Down Syndrome?
Down syndrome is not a single uniform condition. There are three distinct types, each differing in how the extra chromosome 21 appears in the body's cells. Understanding these types matters because they can affect prognosis, recurrence risk, and family planning.
| Type | % of Cases | Description |
|---|---|---|
| Trisomy 21 | ~95% | An extra chromosome 21 in every cell |
| Mosaic Down Syndrome | ~2% | Extra chromosome 21 in some, not all, cells |
| Translocation | ~3% | Part of chromosome 21 attaches to another chromosome |
Trisomy 21 is by far the most prevalent type and results from a random error during the formation of egg or sperm cells. Mosaic Down syndrome tends to be associated with milder features because not every cell carries the extra chromosome. Translocation Down syndrome is the only type that can be inherited from a parent, making genetic counseling particularly valuable for families in this category.
What Are the Common Signs and Features?
Down syndrome is associated with a range of physical characteristics and developmental features. Physically, individuals may have upward-slanting eyes, a flattened facial profile, a single deep crease across the palm, low muscle tone (hypotonia), and a shorter stature. Intellectually, individuals with Down syndrome experience mild to moderate cognitive delays, though the degree varies significantly from person to person.
Health-wise, Down syndrome is associated with an increased risk of congenital heart defects (present in about 40–50% of cases), thyroid disorders, hearing loss, vision problems, and a higher susceptibility to respiratory infections. However, with the right medical support, early intervention therapies, and a nurturing environment, people with Down syndrome can thrive and participate fully in society.
How Is Down Syndrome Diagnosed? What Tests Are Available?
Prenatal testing for Down syndrome falls into two broad categories: screening tests and diagnostic tests. Screening tests assess the likelihood of Down syndrome but cannot confirm it. Diagnostic tests, on the other hand, examine the chromosomes directly and can provide a definitive answer. Understanding the differences between these tests is critical for informed decision-making during pregnancy.
| Test | Type | Timing | Accuracy | Risk to Fetus |
|---|---|---|---|---|
| First Trimester Screening | Screening | Weeks 10–13 | ~85% | None |
| Quad Screen | Screening | Weeks 15–20 | ~80% | None |
| NIPT | Screening | Week 10+ | >99% | None |
| Amniocentesis | Diagnostic | Weeks 15–20 | ~99.9% | ~0.1–0.3% |
| CVS | Diagnostic | Weeks 10–13 | ~99.9% | ~0.5–1% |
First trimester screening combines a blood test measuring pregnancy-associated plasma protein-A (PAPP-A) and human chorionic gonadotropin (hCG) with an ultrasound measurement of the fluid at the back of the baby's neck (nuchal translucency). The quad screen, performed in the second trimester, measures four substances in the mother's blood to estimate risk. Amniocentesis involves extracting a small amount of amniotic fluid, while chorionic villus sampling (CVS) removes a small piece of placental tissue. Both provide near-certain results but carry small procedural risks.
What Makes NIPT Stand Out from Other Tests?
Non-Invasive Prenatal Testing, commonly known as NIPT, has transformed prenatal screening for Down syndrome since its introduction into clinical practice around 2011. NIPT is a simple blood draw from the mother, typically performed as early as 10 weeks into pregnancy. It analyzes cell-free fetal DNA (cfDNA) — fragments of the baby's DNA that circulate in the mother's bloodstream — and can detect chromosomal abnormalities with remarkable accuracy.
What sets NIPT apart is its exceptional sensitivity and specificity. For Down syndrome specifically, NIPT has a detection rate exceeding 99%, with a false positive rate of less than 0.1%. This is significantly higher than traditional first trimester screening (approximately 85%) or the quad screen (approximately 80%). Because NIPT carries no risk to the fetus — it is simply a maternal blood draw — many healthcare providers now recommend it as the preferred first-line screening option, particularly for women at higher risk, such as those who are over 35 years of age, have had a previous pregnancy affected by a chromosomal condition, or have abnormal results from prior screening tests.
It is important to note that NIPT remains a screening test, not a diagnostic test. A positive NIPT result should always be followed up with a diagnostic test such as amniocentesis or CVS for confirmation before any major decisions are made. Additionally, NIPT can also screen for other chromosomal conditions such as Trisomy 18 (Edwards syndrome), Trisomy 13 (Patau syndrome), and sex chromosome abnormalities, making it a comprehensive screening tool in a single test.
For expectant parents in India, access to advanced prenatal screening has expanded significantly in recent years. The NIPT test in Pune is now readily available through accredited diagnostic centres and hospitals, making it easier than ever for families to get early, reliable chromosomal screening without having to travel to larger metros. Pune’s growing healthcare infrastructure means that women can access high-quality NIPT services close to home, typically within the first trimester of pregnancy.
One standout option in this space is the Greenarray NIPT, a comprehensive non-invasive prenatal test designed to provide highly accurate chromosomal analysis from a simple maternal blood sample. Greenarray NIPT screens for Trisomy 21 (Down syndrome), Trisomy 18, Trisomy 13, and sex chromosome aneuploidies, all from a single test performed as early as 10 weeks of gestation. With its high sensitivity, rapid turnaround time, and detailed reporting, Greenarray NIPT is increasingly being recommended by obstetricians and maternal-fetal medicine specialists across India as a trusted and reliable prenatal screening solution. It combines the gold-standard benefits of cfDNA-based testing with an accessible and patient-friendly experience, making it a preferred choice for families seeking peace of mind early in pregnancy.
What Happens After a Diagnosis?
Receiving a diagnosis of Down syndrome — whether prenatally or after birth — can be an emotional and overwhelming experience for many families. It is important to remember that a diagnosis is the beginning of a journey, not an end. Parents are encouraged to connect with genetic counselors, pediatric specialists, and Down syndrome support organizations to build a network of expertise and community.
Early intervention is one of the most powerful tools available. Speech therapy, occupational therapy, and physical therapy can significantly improve developmental outcomes when started early. Many children with Down syndrome attend mainstream schools with appropriate support and go on to lead independent or semi-independent adult lives. Advances in medical care over the past few decades have increased the life expectancy of people with Down syndrome from around 25 years in the 1980s to over 60 years today.
Down syndrome is a condition, not a limitation. It shapes a person's journey, but it does not define their potential. As scientific understanding continues to evolve and societal awareness grows, individuals with Down syndrome are being recognized for their unique abilities, perspectives, and contributions. Whether you are a parent navigating a new diagnosis, a healthcare provider seeking to offer informed guidance, or simply someone looking to learn more, understanding Down syndrome is a step toward a more inclusive and compassionate world.